NEXGEL, INC. Operating Lease, Expense
NEXGEL, INC. (NXGL) reported Operating Lease, Expense of $86.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-17
- NEXGEL, INC. operating lease, expense for the quarter ending 2026-06-30 was $0.00.
- NEXGEL, INC. operating lease, expense for the quarter ending 2026-03-31 was $86.00K, a 21.13% increase year-over-year.
- NEXGEL, INC. operating lease, expense for the quarter ending 2025-12-31 was $89.00K, a 14.42% decline year-over-year.
- NEXGEL, INC. operating lease, expense for the quarter ending 2025-09-30 was $154.00K, a 285.00% increase year-over-year.
- NEXGEL, INC. operating lease, expense for fiscal 2025 was $314.00K, a 9.41% increase from fiscal 2024.
- NEXGEL, INC. operating lease, expense for fiscal 2024 was $287.00K, a 5.28% decline from fiscal 2023.
- NEXGEL, INC. operating lease, expense for fiscal 2023 was $303.00K, a 23.17% increase from fiscal 2022.
- NEXGEL, INC. operating lease, expense for fiscal 2022 was $246.00K, a 5.58% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $86.00K 10-Q · filed 2026-08-17 | $175.00K derived: sum of 3 quarters · filed 2026-08-17 | $329.00K derived: sum of 4 quarters · filed 2026-08-17 | |
| 2026-03-31 | $86.00K 10-Q · filed 2026-05-14 | $175.00K derived: sum of 2 quarters · filed 2026-05-14 | $329.00K derived: sum of 3 quarters · filed 2026-05-14 | $329.00K derived: sum of 4 quarters · filed 2026-08-17 | |
| 2025-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $243.00K derived: sum of 2 quarters · filed 2026-03-31 | $243.00K derived: sum of 3 quarters · filed 2026-08-17 | $314.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $154.00K derived: sum of 2 quarters · filed 2026-08-17 | $225.00K 10-Q · filed 2025-11-12 | $329.00K derived: sum of 4 quarters · filed 2026-08-17 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $71.00K 10-Q · filed 2026-08-17 | $143.00K 10-Q · filed 2025-08-12 | $175.00K derived: sum of 3 quarters · filed 2026-08-17 | $215.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $71.00K 10-Q · filed 2026-05-14 | $175.00K derived: sum of 2 quarters · filed 2026-05-14 | $215.00K derived: sum of 3 quarters · filed 2026-05-14 | $287.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $144.00K derived: sum of 2 quarters · filed 2026-03-31 | $216.00K derived: sum of 3 quarters · filed 2026-03-31 | $287.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $112.00K derived: sum of 2 quarters · filed 2025-11-12 | $183.00K 10-Q · filed 2025-11-12 | $289.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $143.00K 10-Q · filed 2025-08-12 | $249.00K derived: sum of 3 quarters · filed 2025-08-12 | $310.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $71.00K 10-Q · filed 2025-05-13 | $177.00K derived: sum of 2 quarters · filed 2025-05-13 | $238.00K derived: sum of 3 quarters · filed 2025-05-13 | $309.00K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $167.00K derived: sum of 2 quarters · filed 2025-03-27 | $238.00K derived: sum of 3 quarters · filed 2025-03-27 | $303.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $132.00K derived: sum of 2 quarters · filed 2024-11-13 | $197.00K 10-Q · filed 2024-11-13 | $288.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $136.00K 10-Q · filed 2024-08-19 | $227.00K derived: sum of 3 quarters · filed 2024-08-19 | $279.00K derived: sum of 4 quarters · filed 2024-08-19 | |
| 2023-03-31 | $65.00K 10-Q · filed 2024-05-13 | $156.00K derived: sum of 2 quarters · filed 2024-05-13 | $208.00K derived: sum of 3 quarters · filed 2024-05-13 | $311.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $143.00K derived: sum of 2 quarters · filed 2024-04-10 | $246.00K derived: sum of 3 quarters · filed 2024-04-10 | $246.00K 10-K · filed 2024-04-10 | |
| 2022-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $155.00K derived: sum of 2 quarters · filed 2023-11-13 | $155.00K 10-Q · filed 2023-11-13 | $257.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $103.00K 10-Q · filed 2022-08-10 | $103.00K 10-Q · filed 2023-08-14 | $205.00K derived: sum of 3 quarters · filed 2023-05-15 | ||
| 2022-03-31 | $61.00K 10-Q · filed 2023-05-15 | $102.00K derived: sum of 2 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $233.00K 10-K · filed 2023-03-28 | |||
| 2021-09-30 | $192.00K 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | $103.00K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |